Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
phase 3
Biotech
Novartis’ phase 3 wins in Sjögren's see high placebo effect
Novartis is pulling back the curtain on late-stage Sjögren's wins, revealing an edge over placebo in both studies.
Gabrielle Masson
Oct 29, 2025 12:03pm
BridgeBio's calcium deficiency candidate scores phase 3 win
Oct 29, 2025 7:00am
Neuphoria nixes social anxiety program after phase 3 flop
Oct 21, 2025 10:44am
Praxis plots path to FDA after phase 3 wins in essential tremor
Oct 16, 2025 11:48am
Cytokinetics’ ph. 3 cardio win sends stock soaring
Sep 2, 2025 2:05pm
Spine BioPharma misses primary endpoint in back pain phase 3
Aug 1, 2025 10:24am
